Madeleine Antonsson

1.4k total citations
20 papers, 1.1k citations indexed

About

Madeleine Antonsson is a scholar working on Molecular Biology, Oncology and Gastroenterology. According to data from OpenAlex, Madeleine Antonsson has authored 20 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Gastroenterology. Recurrent topics in Madeleine Antonsson's work include Drug Transport and Resistance Mechanisms (5 papers), Gastroesophageal reflux and treatments (4 papers) and RNA Interference and Gene Delivery (4 papers). Madeleine Antonsson is often cited by papers focused on Drug Transport and Resistance Mechanisms (5 papers), Gastroesophageal reflux and treatments (4 papers) and RNA Interference and Gene Delivery (4 papers). Madeleine Antonsson collaborates with scholars based in Sweden, United Kingdom and Finland. Madeleine Antonsson's co-authors include Markus Fridén, Margareta Hammarlund‐Udenaes, Ulf Bredberg, Lars Weidolf, Angela Äbelö, Tommy B. Andersson, Inger Skånberg, Susanne Winiwarter, Anders Lehmann and Hong Wan and has published in prestigious journals such as Gastroenterology, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Madeleine Antonsson

20 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Madeleine Antonsson Sweden	14	333	280	247	219	175	20	1.1k
I Roots Germany	14	218 0.7×	412 1.5×	25 0.1×	80 0.4×	569 3.3×	19	1.2k
Keiji Kubo Japan	19	49 0.1×	609 2.2×	103 0.4×	268 1.2×	65 0.4×	49	1.9k
Achiel Van Peer Belgium	19	202 0.6×	208 0.7×	13 0.1×	129 0.6×	319 1.8×	43	1.2k
Bangning Yu United States	12	295 0.9×	176 0.6×	11 0.0×	141 0.6×	258 1.5×	22	1.1k
B. Norlander Sweden	23	144 0.4×	168 0.6×	52 0.2×	82 0.4×	153 0.9×	53	1.1k
Ernesto Callegari United States	15	342 1.0×	421 1.5×	10 0.0×	84 0.4×	396 2.3×	29	1.3k
Venkatesh Pilla Reddy United States	19	305 0.9×	325 1.2×	13 0.1×	37 0.2×	207 1.2×	56	1.1k
Nancy Agrawal United States	20	143 0.4×	278 1.0×	18 0.1×	101 0.5×	175 1.0×	39	1.1k
Markus Jerling Sweden	20	235 0.7×	283 1.0×	13 0.1×	78 0.4×	308 1.8×	44	1.3k
Joanne Wang United States	17	588 1.8×	363 1.3×	14 0.1×	101 0.5×	118 0.7×	29	1.2k

Countries citing papers authored by Madeleine Antonsson

Since Specialization

Citations

This map shows the geographic impact of Madeleine Antonsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Madeleine Antonsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Madeleine Antonsson more than expected).

Fields of papers citing papers by Madeleine Antonsson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Madeleine Antonsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Madeleine Antonsson. The network helps show where Madeleine Antonsson may publish in the future.

Co-authorship network of co-authors of Madeleine Antonsson

This figure shows the co-authorship network connecting the top 25 collaborators of Madeleine Antonsson. A scholar is included among the top collaborators of Madeleine Antonsson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Madeleine Antonsson. Madeleine Antonsson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Berman, Carol W., Madeleine Antonsson, Sándor Bátkai, et al.. (2023). OSWG Recommended Approaches to the Nonclinical Pharmacokinetic (ADME) Characterization of Therapeutic Oligonucleotides. Nucleic Acid Therapeutics. 33(5). 287–305. 7 indexed citations

Antonsson, Madeleine, et al.. (2023). Plasma Pharmacokinetics of N-Acetylgalactosamine-Conjugated Small-Interfering Ribonucleic Acids (GalNAc-Conjugated siRNAs). Clinical Pharmacokinetics. 62(12). 1661–1672. 6 indexed citations

Ericson, Elke, Anne‐Christine Andréasson, Carly I. Dix, et al.. (2022). Hepatic patatin‐like phospholipase domain‐containing 3 levels are increased in I148M risk allele carriers and correlate with NAFLD in humans. Hepatology Communications. 6(10). 2689–2701. 14 indexed citations

Andersson, Shalini, Madeleine Antonsson, Marie Elebring, Rasmus Jansson‐Löfmark, & Lars Weidolf. (2018). Drug metabolism and pharmacokinetic strategies for oligonucleotide- and mRNA-based drug development. Drug Discovery Today. 23(10). 1733–1745. 46 indexed citations

Gennemark, Peter, Daniel Lindén, Karolina Ploj, et al.. (2017). Translational Modeling to Guide Study Design and Dose Choice in Obesity Exemplified by AZD1979, a Melanin‐concentrating Hormone Receptor 1 Antagonist. CPT Pharmacometrics & Systems Pharmacology. 6(7). 458–468. 6 indexed citations

Johansson, Anders, Christian Löfberg, Madeleine Antonsson, et al.. (2016). Discovery of (3-(4-(2-Oxa-6-azaspiro[3.3]heptan-6-ylmethyl)phenoxy)azetidin-1-yl)(5-(4-methoxyphenyl)-1,3,4-oxadiazol-2-yl)methanone (AZD1979), a Melanin Concentrating Hormone Receptor 1 (MCHr1) Antagonist with Favorable Physicochemical Properties. Journal of Medicinal Chemistry. 59(6). 2497–2511. 49 indexed citations

Carlsson, Leif, Yuping Wang, Chien-Hsi Chen, et al.. (2016). Abstract 15533: A Biocompatible Chemically Modified mRNA Drives Sustained VEGF-A Protein Production, Human Endothelial Angiogenesis and Epicardial Progenitor Expansion, and Reduces Infarct Size and Partially Reverses Global Cardiac Dysfunction When Intracardially Injected One Week Post-Myocardial Infarction in the Pig. 134. 1 indexed citations

Ploj, Karolina, Lambertus Benthem, Peter Gennemark, et al.. (2016). Effects of a novel potent melanin‐concentrating hormone receptor 1 antagonist, AZD1979, on body weight homeostasis in mice and dogs. British Journal of Pharmacology. 173(18). 2739–2751. 19 indexed citations

Fridén, Markus, et al.. (2014). Identification of positron emission tomography (PET) tracer candidates by prediction of the target-bound fraction in the brain. EJNMMI Research. 4(1). 50–50. 23 indexed citations

10.

Gennemark, Peter, Rasmus Jansson‐Löfmark, Peter Brodin, et al.. (2013). A modeling approach for compounds affecting body composition. Journal of Pharmacokinetics and Pharmacodynamics. 40(6). 651–667. 15 indexed citations

11.

Plowright, Alleyn T., Karolina Nilsson, Madeleine Antonsson, et al.. (2012). Discovery of Agonists of Cannabinoid Receptor 1 with Restricted Central Nervous System Penetration Aimed for Treatment of Gastroesophageal Reflux Disease. Journal of Medicinal Chemistry. 56(1). 220–240. 11 indexed citations

12.

Lehmann, A., Madeleine Antonsson, L. Ashley Blackshaw, et al.. (2011). Different in vitro and in vivo profiles of substituted 3‐aminopropylphosphinate and 3‐aminopropyl(methyl)phosphinate GABA_B receptor agonists as inhibitors of transient lower oesophageal sphincter relaxation. British Journal of Pharmacology. 165(6). 1757–1772. 5 indexed citations

13.

Chen, Hongming, Susanne Winiwarter, Markus Fridén, Madeleine Antonsson, & Ola Engkvist. (2011). In silico prediction of unbound brain-to-plasma concentration ratio using machine learning algorithms. Journal of Molecular Graphics and Modelling. 29(8). 985–995. 52 indexed citations

14.

Lehmann, Anders, Madeleine Antonsson, L. Ashley Blackshaw, et al.. (2009). (R)-(3-Amino-2-fluoropropyl) Phosphinic Acid (AZD3355), a Novel GABAB Receptor Agonist, Inhibits Transient Lower Esophageal Sphincter Relaxation through a Peripheral Mode of Action. Journal of Pharmacology and Experimental Therapeutics. 331(2). 504–512. 39 indexed citations

15.

Fridén, Markus, et al.. (2009). Development of a High-Throughput Brain Slice Method for Studying Drug Distribution in the Central Nervous System. Drug Metabolism and Disposition. 37(6). 1226–1233. 87 indexed citations

16.

Fridén, Markus, Susanne Winiwarter, Ola Bengtsson, et al.. (2009). Structure−Brain Exposure Relationships in Rat and Human Using a Novel Data Set of Unbound Drug Concentrations in Brain Interstitial and Cerebrospinal Fluids. Journal of Medicinal Chemistry. 52(20). 6233–6243. 167 indexed citations

17.

Fridén, Markus, et al.. (2007). In Vitro Methods for Estimating Unbound Drug Concentrations in the Brain Interstitial and Intracellular Fluids. Drug Metabolism and Disposition. 35(9). 1711–1719. 146 indexed citations

18.

Andersson, Tommy, Eva Bredberg, Maria Sunzel, Madeleine Antonsson, & Lars Weidolf. (2000). Pharmacokinetics (PK) and effect on pentagastrin stimulated peak acid output (PAO) of omeprazole (O) and its 2 optical isomers, S-omeprazole/esomeprazole (E) and R-omeprazole (R-O). Gastroenterology. 118(4). A1210–A1210. 21 indexed citations

19.

Äbelö, Angela, et al.. (2000). Stereoselective Metabolism of Omeprazole by Human Cytochrome P450 Enzymes. Drug Metabolism and Disposition. 28(8). 966–972. 224 indexed citations

20.

Lehmann, Anders, et al.. (1999). Activation of the GABAB receptor inhibits transient lower esophageal sphincter relaxations in dogs. Gastroenterology. 117(5). 1147–1154. 132 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact